Silexion Therapeutics Corp. (SLXN)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 71
-0.04
-1.4545%
$
1.31M Market Cap
- P/E Ratio
- Div Yield
305,872 Volume
- Eps
$ 2.75
Previous Close Want to track SLXN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Silexion Therapeutics Corp. (SLXN) Statistics
Valuation metrics
Market Cap 1.31M
Enterprise value -665.55K
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 3.47
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 136.77K
Average volume (90 days) 5.62M
Price summary
52-Week low 2.31
52-Week high 223.6
Beta -
50-Day moving average 1.7
200-Day moving average 1.82
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 29 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.81%
Return on equity -5.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -39.96
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.47
Total debt (mrq) -
Total Debt/Equity (mrq) 1.5
Current ratio (mrq) 1%
Book value per share (mrq) 0.9
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
